Published in Gastric Cancer on September 03, 2011
CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases. World J Surg Oncol (2012) 0.90
Chemotherapy and resection for gastric cancer with synchronous liver metastases. World J Gastroenterol (2013) 0.89
Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.83
Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer. Clin Exp Metastasis (2013) 0.78
Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surg (2017) 0.75
Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection. BMC Cancer (2017) 0.75
Evaluation of hepatectomy and palliative local treatments for gastric cancer patients with liver metastases: a propensity score matching analysis. Oncotarget (2017) 0.75
The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Epidemiology and management of liver metastases from colorectal cancer. Ann Surg (2006) 3.37
Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg (2004) 2.86
Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw (2010) 1.85
Hepatic resection for metastatic tumors from gastric cancer. Ann Surg (2002) 1.79
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery (2003) 1.67
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg (1994) 1.32
Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl (2000) 1.32
Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology (2003) 1.29
A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol (2001) 1.27
Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg (2002) 1.26
Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol (1997) 1.24
Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology (2002) 1.08
Hepatic resection for metastatic tumors from noncolorectal carcinoma. Hepatogastroenterology (2001) 1.04
Resection of liver metastasis from gastric adenocarcinoma. Hepatogastroenterology (2001) 1.03
Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery (1991) 1.02
Liver resections in metastatic gastric cancer. HPB (Oxford) (2010) 1.00
Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int (2010) 0.99
Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg (2009) 0.93
Liver resection for metastatic gastric cancer. Eur J Surg Oncol (2008) 0.92
Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma. Yonsei Med J (2008) 0.85
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol (2008) 3.64
Limberg Flap Is Rhombic, Not Rhomboid. Plast Reconstr Surg (2016) 2.56
Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med (2011) 2.30
Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock (2009) 1.82
Hepatic artery thrombosis after adult liver transplantation. Liver Transpl (2003) 1.74
The heme oxygenase-carbon monoxide system: regulation and role in stress response and organ failure. Intensive Care Med (2008) 1.68
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Diagnosis and treatment of arterial steal syndromes in liver transplant recipients. Liver Transpl (2003) 1.58
Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg (2003) 1.48
Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon (2012) 1.47
The delay of rearterialization after initial portal reperfusion in living donor liver transplantation significantly determines the development of microvascular graft dysfunction. J Hepatol (2004) 1.46
Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol (2012) 1.32
Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl (2002) 1.27
Readmission to a surgical intensive care unit: incidence, outcome and risk factors. Crit Care (2008) 1.20
Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume. Radiology (2006) 1.19
TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Eur J Cancer (2010) 1.16
Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem (2007) 1.12
Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology (2002) 1.11
Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. Int J Colorectal Dis (2012) 1.10
Epidemiology of and factors associated with end-of-life decisions in a surgical intensive care unit. Crit Care Med (2010) 1.10
FGFR1 expression and gene copy numbers in human lung cancer. Virchows Arch (2012) 1.07
Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact. Cell Commun Signal (2013) 1.06
Anemia and blood transfusion in a surgical intensive care unit. Crit Care (2010) 1.06
Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int J Oncol (2006) 1.06
Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J Clin Pathol (2011) 1.06
CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl (2002) 1.05
Medical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications. J Crohns Colitis (2011) 1.03
Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology (2005) 1.03
Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation. Liver Transpl (2005) 1.02
Identification of specific protein markers in microdissected hepatocellular carcinoma. J Proteome Res (2007) 1.01
Down-regulation of MTUS1 in human colon tumors. Oncol Rep (2010) 1.01
Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem Cell Biol (2009) 1.00
Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol (2010) 0.96
Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis (2011) 0.93
Bariatric surgery to treat obesity. Semin Nephrol (2013) 0.93
Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis (2009) 0.92
New methods for clinical pathways-Business Process Modeling Notation (BPMN) and Tangible Business Process Modeling (t.BPM). Langenbecks Arch Surg (2012) 0.91
PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration. Oncol Rep (2006) 0.89
Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature. Langenbecks Arch Surg (2012) 0.89
Ruptured aneurysm of the ulnar artery in a woman with neurofibromatosis. J Vasc Surg (2009) 0.89
Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation (2003) 0.88
Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. J Cell Physiol (2007) 0.88
Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis (2012) 0.88
Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther (2002) 0.87
Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis. Ther Apher Dial (2009) 0.87
Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transplant (2004) 0.86
High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol (2011) 0.86
Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. Regul Pept (2005) 0.85
Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy. Eur J Heart Fail (2009) 0.85
Heme oxygenase-1 protects human hepatocytes in vitro against warm and cold hypoxia. J Hepatol (2004) 0.85
Unusual course of an abdominal aortic aneurysm in a patient treated with chemotherapy for gastric cancer. J Vasc Surg (2011) 0.85
Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer. World J Surg (2012) 0.85
Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbecks Arch Surg (2003) 0.85
Waiting time, not donor-risk-index, is a major determinant for beneficial outcome after liver transplantation in high-MELD patients. Ann Transplant (2013) 0.84
Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant (2003) 0.84
Treatment of osteoporosis after liver transplantation with ibandronate. Transpl Int (2010) 0.84
Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach. J Proteome Res (2005) 0.84
Nested stromal epithelial tumor of the liver--liver transplantation and follow-up. J Gastrointest Cancer (2011) 0.84
Paradoxical carbon dioxide embolism during laparoscopic unroofing of a recurrent nonparasitic liver cyst. Can J Surg (2009) 0.83
Treatment of perigraft seroma in expanded polytetrafluoroethylene grafts by sequential fibrin sealing of the outer graft surface. Ann Vasc Surg (2010) 0.83
Do patients in rural Malawi benefit from upper gastrointestinal endoscopy? Trop Doct (2009) 0.83
A quantitative co-localization analysis of large unspliced tenascin-C(L) and laminin-5/gamma2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy. J Oral Pathol Med (2007) 0.83
Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation. Ann Transplant (2002) 0.83
Noninvasive in vivo analysis of the human hepatic microcirculation using orthogonal polorization spectral imaging. Transplantation (2003) 0.83
A survival-based scoring-system for initial graft function following orthotopic liver transplantation. Transpl Int (2003) 0.83
Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience. Ther Apher Dial (2014) 0.83
Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery. J Cancer Res Clin Oncol (2010) 0.82
In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation. Am J Transplant (2005) 0.82
DTG procurement guidelines in heart beating donors. Transpl Int (2011) 0.82
Long-term follow-up in 54 surgically treated patients with gastrointestinal stromal tumours. Langenbecks Arch Surg (2008) 0.80
Impact of stable PGI₂ analog iloprost on early graft viability after liver transplantation: a pilot study. Clin Transplant (2011) 0.80
Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Oncol Rep (2009) 0.80
Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience. Langenbecks Arch Surg (2014) 0.79
Flow pattern and shear stress distribution of distal end-to-side anastomoses. A comparison of the instantaneous velocity fields obtained by particle image velocimetry. J Biomech (2004) 0.79